WaferGen Signs Exclusive Distribution Agreements for SmartSlide Micro-Incubation System
News Jul 29, 2008
WaferGen signs exclusive SmartSlide distribution agreement in Switzerland, Taiwan and the Nordic Region.
WaferGen Biosystems, Inc. announced the signing of exclusive distribution agreements for the company's SmartSlide™ Micro-Incubation System with Bucher Biotec AG in Switzerland, Unimed Healthcare Inc. in Taiwan and AH diagnostics AS in the Nordic region (Denmark, Sweden, Norway and Finland).
The distributor agreements cover WaferGen's entire family of SmartSlide Micro-Incubation System products. Bucher Biotec, Unimed Healthcare and AH diagnostics are each distributors of products and services to cell biologists and stem cell researchers in the life science markets within their geographic areas of focus.
WaferGen's SmartSlide Micro-Incubation System is a first-of-its-kind family of integrated fluidics exchange micro-incubation products that work seamlessly with inverted microscopes. This technology is enabling cell biology and stem cell researchers to conduct complex time lapse imaging studies to characterize, differentiate and proliferate cells, as well as grow stem, primary and other difficult to cultivate cells in consistently optimal physiological conditions.
"These key distributor agreements represent yet another important milestone in our strategic efforts to expand the reach of our SmartSlide Micro-Incubation System into new key foreign markets," stated Alnoor Shivji, WaferGen's chairman and chief executive officer.
"This innovative platform is already providing critical performance advantages to researchers in several valuable international markets through our existing distributor agreements in Germany, France, the United Kingdom, Australia, Singapore and the Benelux. In keeping with this strategy, we expect to continue to build our SmartSlide Micro-Incubation System customer base with additional international distributor agreements this year."
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.